Business Description
Synthetic MR AB
SIC : 3845
ISIN : SE0015987946
Total Employee Number:
40Compare
Compare
Traded in other countries / regions
SYNT.Sweden9480.Germany0G79.UKSYNMF.USA IPO Date
2024-07-04Description
SyntheticMR AB is a Swedish medical software company that develops and markets imaging solutions for magnetic resonance imaging (MRI), primarily in neuroradiology. Its flagship product, SyMRI, quantifies absolute tissue properties of the brain and generates multiple contrast-weighted images from a single rapid scan, along with automatic segmentation of brain biomarkers and quantitative data. The company also offers the cNeuro product family through Combinostics, providing AI-driven decision support for clinicians diagnosing neurological diseases. Customers are mainly hospitals, imaging clinics, and healthcare providers. SyntheticMR operates across the Americas, Europe, and the Asia-Pacific region, with Europe representing the largest share of revenue. Its revenue model combines software licenses, recurring fees, and related services sold to healthcare institutions and imaging centers worldwide.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.62 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.14 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.39 | |||||
Beneish M-Score | -3.28 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.7 | |||||
3-Year FCF Growth Rate | 27.1 | |||||
3-Year Book Growth Rate | -9.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 48.84 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.28 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.39 | |||||
9-Day RSI | 38.54 | |||||
14-Day RSI | 41.24 | |||||
3-1 Month Momentum % | 13.93 | |||||
6-1 Month Momentum % | -52.23 | |||||
12-1 Month Momentum % | -87.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.63 | |||||
Quick Ratio | 2.63 | |||||
Cash Ratio | 0.93 | |||||
Days Sales Outstanding | 109.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.4 | |||||
Shareholder Yield % | -63.66 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 110.96 | |||||
Operating Margin % | -75.11 | |||||
Net Margin % | -75.69 | |||||
EBITDA Margin % | -53.3 | |||||
FCF Margin % | -23.98 | |||||
OCF Margin % | -23.92 | |||||
ROE % | -35.89 | |||||
ROA % | -27.77 | |||||
ROIC % | -32.5 | |||||
3-Year ROIIC % | -126.02 | |||||
ROC (Joel Greenblatt) % | -1545.64 | |||||
ROCE % | -33.78 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 338 | |||||
PS Ratio | 0.64 | |||||
PB Ratio | 0.36 | |||||
Price-to-Tangible-Book | 0.95 | |||||
EV-to-EBIT | -0.48 | |||||
EV-to-Forward-EBIT | -1.6 | |||||
EV-to-EBITDA | -0.66 | |||||
EV-to-Forward-EBITDA | -3.21 | |||||
EV-to-Revenue | 0.36 | |||||
EV-to-Forward-Revenue | 0.61 | |||||
EV-to-FCF | -1.13 | |||||
Price-to-GF-Value | 0.21 | |||||
Price-to-Median-PS-Value | 0.03 | |||||
| Price-to-Net-Current-Asset-Value | 0.95 | |||||
Earnings Yield (Greenblatt) % | -208.19 | |||||
FCF Yield % | -41.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Synthetic MR AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5.269 | ||
| EPS (TTM) (€) | -0.058 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 101.38 | ||
| 14-Day RSI | 41.24 | ||
| 14-Day ATR (€) | 0.006924 | ||
| 20-Day SMA (€) | 0.02348 | ||
| 12-1 Month Momentum % | -87.42 | ||
| 52-Week Range (€) | 0.0084 - 0.224 | ||
| Shares Outstanding (Mil) | 89.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synthetic MR AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synthetic MR AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-16 | In 147 days | ||
| Third quarter earnings results for 2026 | 2026-11-25 | In 64 days | ||
| Second quarter earnings results for 2026 | 2026-08-25 | 0.03 (+10.71%) | ||
| General meeting for 2025 | 2026-05-27 18:00 | 0.04 (-9.65%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 0.07 (+0.58%) | ||
| Annual report for 2025 | 2026-04-09 | 0.07 (+23.13%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-06 | 0.08 (-10.71%) | ||
| Third quarter earnings results for 2025 | 2025-11-28 | 0.14 (-3.47%) | ||
| Second quarter earnings results for 2025 | 2025-08-26 | 0.28 (-0.33%) | ||
| General meeting for 2024 | 2025-05-20 18:00 | 0.32 (+1.16%) |
Show
Entries
Synthetic MR AB Frequently Asked Questions
What is Synthetic MR AB(STU:9480)'s stock price today?
The current price of STU:9480 is €0.02. The 52 week high of STU:9480 is €0.22 and 52 week low is €0.01.
When is next earnings date of Synthetic MR AB(STU:9480)?
The next earnings date of Synthetic MR AB(STU:9480) is 2026-11-25.
Does Synthetic MR AB(STU:9480) pay dividends? If so, how much?
Synthetic MR AB(STU:9480) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers